SLRN News

US IPO Market Slowly Rebuilds in 2023 After sinking to historic lows in the prior year, the US IPO market started to rebuild in 2023, laying the groundwork for the next upcycle. 108 IPOs raised a combined $19.4 billion, a slow year by historical standards but a significant increase from 2022. Issuance was weighed...read more

Following the Independence Day lull, the July IPO market is set to warm up with two biotechs that plan to raise $75+ million. The pair are expected to price this week. Apogee Therapeutics (APGE) plans to raise $250 million at the $16 midpoint in a deal led by Jefferies. At the midpoint, it would be the second-largest biotech IPO since the start of 2022, after...read more

US IPO Market Gains Momentum in the 2Q In the second quarter of 2023, 23 IPOs raised a combined $6.6 billion. While deal count held steady from the prior-year period, quarterly proceeds were the highest in six quarters, even without J&J spin-off Kenvue's $3.8 billion IPO. Nine IPOs raised $100 million or more,...read more

Four sizable IPOs raised a combined $4.9 billion in May, the biggest month for proceeds since December 2021. May activity was well below the 10-year average for deal count (19 IPOs) but on par for proceeds ($5.0B), and the month now accounts for two-thirds of 2023 IPO proceeds to date thanks to its slate of large deals. Issuance was led by J&J’s Kenvue...read more